Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trialBruce E. Sands, Olga Fedorishina, Andrew Greenspan et al.|The Lancet|2022Cited by 295
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome—A Randomized Double-Blind, Placebo-Controlled StudyBarbara Skrzydło-Radomańska, Božena Cukrowská, Beata Prozorow-Król et al.|Nutrients|2020Cited by 95
The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled StudyBarbara Skrzydło-Radomańska, Božena Cukrowská, Beata Prozorow-Król et al.|Nutrients|2021Cited by 82